The model we developed shows that clinically deteriorated, cachectic, with inferior quality of life scores, wild‐type EGFR, and with poor prognostic predictors tend to be classified as short OS (≤90 days), showing biological plausibility, related to cancer‐induced systemic inflammation.40 This evidence concerns the gene EGFR and cancer.